Benchmark Holdings (BMK)

Sector:

Pharma and Biotech

 44.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 48.00
  • 52 Week Low: 34.00
  • Currency: UK Pounds
  • Shares Issued: 739.78m
  • Volume: 43,784
  • Market Cap: £325.50m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
31-Mar-24 Interim 80.22 (7.86) (1.21)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-19 124.01 (58.48) (10.72)p n/a n/a n/a n/a 0.0%
30-Sep-20 105.57 (22.57) (3.80)p n/a n/a n/a n/a 0.0%
30-Sep-21 125.06 (9.18) (1.93)p n/a n/a n/a n/a 0.0%
30-Sep-22 157.71 (21.38) (4.34)p n/a n/a n/a n/a 0.0%
30-Sep-23 169.48 (12.69) (2.41)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-24 169.65 7.95 (1.00)p n/a n/a n/a n/a 0.0%
30-Sep-25 189.55 16.35 1.00p 44.0 n/a n/a n/a 0.0%
30-Sep-26 213.20 24.15 1.70p 25.9 0.4 +70% n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

BMK Market Data

Currency UK Pounds
Share Price 44.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 48.00
52 Week Low 34.00
Volume 43,784
Shares Issued 739.78m
Market Cap £325.50m

BMK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.03% below the market average33.03% below the market average33.03% below the market average33.03% below the market average33.03% below the market average
21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average
Price Trend
41.23% above the market average41.23% above the market average41.23% above the market average41.23% above the market average41.23% above the market average
62.26% above the sector average62.26% above the sector average62.26% above the sector average62.26% above the sector average62.26% above the sector average
Income Not Available
Growth
3.57% above the market average3.57% above the market average3.57% above the market average3.57% above the market average3.57% above the market average
2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average2.86% above the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

BMK Dividends

No dividends found

Trades for 17-Jun-2024

Time Volume / Share Price
16:35 4 @ 44.00p
16:35 1 @ 44.00p
16:35 1 @ 44.00p
16:35 2 @ 44.00p
16:21 4,515 @ 42.72p

BMK Key Personnel

Chair Peter George
CFO Septima Maguire
CEO Trond Williksen

Top of Page